James Strickland, MD
Clinical Cardiac Electrophysiology · The Woodlands, TXNPI 1235276411
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $63,625 of the $98,532 with a category attached, or 64.6%. Boston Scientific accounts for 67.1% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $28,419, 2.8 times the $9,972 reported in 2019.
Across 634 payments — averaging $155.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$66K
- Abbott$14K
- Biotronik Inc.$12K
- Biosense Webster, Inc.$2K
- Impulse Dynamics (USA) Inc.$1K
- E.r. Squibb & Sons, L.L.C.$361
- plus $3K from 22 others
Across 60 payments — averaging $3688.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$211K
- Elutia, Inc.$10K
What the payments were for
- Consulting fees$5,6006%
- Speaking & faculty fees$63,62565%
- Travel & lodging$3,2963%
- Food & beverage$25,97826%
- Other$330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 80 | $66,080 |
| Abbott | 238 | $14,436 |
| Biotronik Inc. | 77 | $12,012 |
| Biosense Webster, Inc. | 90 | $2,060 |
| Impulse Dynamics (USA) Inc. | 21 | $1,068 |
| E.r. Squibb & Sons, L.L.C. | 23 | $361 |
| Merck | 15 | $313 |
| Atricure, Inc. | 4 | $261 |
| Cardiva Medical, Inc. | 8 | $223 |
| Sanofi-aventis U.S. LLC | 13 | $215 |
| Irhythm Technologies, Inc. | 12 | $208 |
| Johnson & Johnson | 5 | $163 |
| Elutia, Inc. | 7 | $153 |
| Medtronic | 1 | $139 |
| Novartis | 6 | $112 |
| Baxter Healthcare | 2 | $109 |
| Lundbeck LLC | 5 | $107 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $92 |
| Boehringer Ingelheim | 4 | $79 |
| Amgen | 5 | $75 |
| Pfizer | 3 | $72 |
| Inspire Medical Systems, Inc. | 3 | $54 |
| BD | 1 | $34 |
| Kestra Medical Technology Services, Inc. | 1 | $26 |
| G Medical Diagnostic Services, Inc. | 1 | $25 |
| Bardy Diagnostics, Inc. | 1 | $22 |
| Cardinal Health 200 LLC | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$64,539
- AVEIR$2,261
- Confirm Rx$2,010
- Quadra Assura CRT Defibrillator$1,887
- Quartet CRT Lead$1,050
- BioMonitor$1,015
- OPTIMIZER$928
- Edora$894
- Carto 3$828
- Acticor 7 VR-T DX$634
- AMPLATZER Occluders$633
- Acticor$494
- Solia$494
- Rivacor$494
- JOT DX$486
- Rivacor 7 DR-T$477
- QUADRA ASSURA$473
- Quadra Allure MP RF CRT Pacemkr$433
- GALLANT$316
- Merlin Connectivity and Remote$287
How this compares
$98,532 in reported general payments places this provider in the 80th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 142 | $128,416 |
| EliquisApixaban | 97 | $72,925 |
| XareltoRivaroxaban | 67 | $68,376 |
| CorlanorIvabradine Hcl | 32 | $22,666 |
| JardianceEmpagliflozin | 16 | $13,080 |
| MultaqDronedarone Hcl | 16 | $12,605 |
| Flecainide Acetate | 106 | $3,004 |
| Metoprolol Succinate | 245 | $2,585 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 50 | $1,565 |
| Digoxin | 91 | $1,353 |
| Amiodarone Hcl | 136 | $1,240 |
| Metoprolol Tartrate | 160 | $1,023 |
| Nifedipine ErNifedipine | 24 | $711 |
| Losartan Potassium | 87 | $668 |
| ClopidogrelClopidogrel Bisulfate | 76 | $622 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $112 | $128,416142 claims |
| PfizerEliquis | $72 | $72,92597 claims |
| Johnson & JohnsonXarelto | $163 | $68,37667 claims |
| AmgenCorlanor | $75 | $22,66632 claims |
| Boehringer IngelheimJardiance | $79 | $13,08016 claims |
| Sanofi-aventis U.S. LLCMultaq | $215 | $12,60516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in The Woodlands
- Michael DelaughterBedford$1.6M
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Dale YooMcKinney$585K
- Rodney HortonAustin$553K
- Jose Cuellar SilvaWebster$502K
- Miguel ValderrabanoHouston$461K
- Theodore TakataFort Worth$396K
- Muhie Dean SabayonGalveston$361K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.